Last reviewed · How we verify
Pfizer-BioNTech mRNA COVID-19 vaccine
Pfizer-BioNTech mRNA COVID-19 vaccine is a Small molecule drug developed by Henry M. Jackson Foundation for the Advancement of Military Medicine. It is currently FDA-approved. Also known as: Comirnaty.
At a glance
| Generic name | Pfizer-BioNTech mRNA COVID-19 vaccine |
|---|---|
| Also known as | Comirnaty |
| Sponsor | Henry M. Jackson Foundation for the Advancement of Military Medicine |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Assessing Safety of Coronavirus Infection (COVID-19) Messenger RNA (mRNA) Vaccine Administration in the Setting of a Previous Adverse Reaction (PHASE4)
- Evaluation of Full Versus Fractional Dose of COVID-19 Vaccine Given as a Booster for the Prevention of COVID-19 in Adults in Mongolia. (PHASE3)
- Use and Effectiveness of COVID-19 Vaccines Using State Vaccine Registries and Insurance Claims Data
- Evaluating Safety and Immune Response of Janssen, Moderna, Pfizer/BNT, and Novavax COVID-19 Vaccines for Same and Mixed Boosters in Adolescents and Adults Aged 12-64 With and Without HIV in Kenya, DRC, and Rwanda (PHASE2)
- Self-Amplifying mRNA COVID-19 Vaccine (LUNAR-COV19) Versus Comirnaty Vaccine in Adult Hematopoietic Cell Transplant Patients (PHASE2)
- Lymph Node Aspiration to Decipher the Immune Response of Beta-variant Recombinant Protein Booster Vaccine (VidPrevtyn Beta, Sanofi) Compared to a Bivalent mRNA Vaccine (Comirnaty Original/Omicron BA.4-5, BioNTech-Pfizer) in Adults Previously Vaccinated With at Least 3 Doses of COVID-19 mRNA Vaccine. (NA)
- COVID Protection After Transplant-Immunosuppression Reduction (PHASE2)
- Study Comparing Safety and Immunogenicity of Intranasal COVID-19 Vaccine and mRNA Booster in Healthy Adults (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Pfizer-BioNTech mRNA COVID-19 vaccine CI brief — competitive landscape report
- Pfizer-BioNTech mRNA COVID-19 vaccine updates RSS · CI watch RSS
- Henry M. Jackson Foundation for the Advancement of Military Medicine portfolio CI
Frequently asked questions about Pfizer-BioNTech mRNA COVID-19 vaccine
What is Pfizer-BioNTech mRNA COVID-19 vaccine?
Pfizer-BioNTech mRNA COVID-19 vaccine is a Small molecule drug developed by Henry M. Jackson Foundation for the Advancement of Military Medicine.
Who makes Pfizer-BioNTech mRNA COVID-19 vaccine?
Pfizer-BioNTech mRNA COVID-19 vaccine is developed and marketed by Henry M. Jackson Foundation for the Advancement of Military Medicine (see full Henry M. Jackson Foundation for the Advancement of Military Medicine pipeline at /company/henry-m-jackson-foundation-for-the-advancement-of-military-medicine).
Is Pfizer-BioNTech mRNA COVID-19 vaccine also known as anything else?
Pfizer-BioNTech mRNA COVID-19 vaccine is also known as Comirnaty.
What development phase is Pfizer-BioNTech mRNA COVID-19 vaccine in?
Pfizer-BioNTech mRNA COVID-19 vaccine is FDA-approved (marketed).
Related
- Manufacturer: Henry M. Jackson Foundation for the Advancement of Military Medicine — full pipeline
- Also known as: Comirnaty
- Compare: Pfizer-BioNTech mRNA COVID-19 vaccine vs similar drugs
- Pricing: Pfizer-BioNTech mRNA COVID-19 vaccine cost, discount & access